Dr. Acosta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Ave 359 De Diego
Fundacion De Investigacion De Diego
San Juan, PR 00927Phone+1 787-722-1248
Education & Training
- University of Puerto RicoFellowship, Hematology and Medical Oncology, 2011 - 2014
- University of Puerto RicoResidency, Internal Medicine, 2008 - 2011
- University of Puerto Rico School of MedicineClass of 2008
Certifications & Licensure
- PR State Medical License 2014 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014.Nizar J Bahlis, Christy Samaras, Donna Reece, Michael Sebag, Jeffrey Matous
Clinical Lymphoma, Myeloma & Leukemia. 2024-12-01 - 22 citationsNivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo
Journal of Clinical Oncology. 2023-03-20 - 11 citationsPomalidomide, dexamethasone, and daratumumab immediately after lenalidomide-based treatment in patients with multiple myeloma: updated efficacy, safety, and health-rel...Nizar J Bahlis, David S Siegel, Gary J Schiller, Christy Samaras, Michael Sebag
Leukemia & Lymphoma. 2022-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: